Pharmaceuticals Brazil

Brazil Narcolepsy Treatment Market Analysis, 2024–2034

Brazil Narcolepsy Treatment Market Industry Trends and Forecast to 2034: Segmented by (Drug Class, Type, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Brazil · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $103.1 Mn Estimated value
Estimate 2025 $112.5 Mn 2.8% of the global market
Projected 2034 $246.3 Mn 119% Adds $133.8 Mn over 9 forecast years
CAGR 2025–2034 9.1% Faster than 51% of 180 Pharmaceuticals markets here
Key players 5
  • Brazil is 2.76% of the global market.
  • In Latin America, the largest is Brazil (this report) at $112.5 Mn.
  • Fastest growing: Brazil (this report) at 9.1% a year.
  • Brazil ranks 1st of 3 by size in Latin America.

Market size projection

Brazil

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$133.8 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Narcolepsy Treatment Market market size by year, Brazil
YearMarket sizeChange that yearSince 2025
2024 (estimate) $103.1 Mn — —
2025 (base) $112.5 Mn +$9.4 Mn —
2026 (forecast) $122.7 Mn +$10.2 Mn +9.1%
2027 (forecast) $133.9 Mn +$11.2 Mn +19%
2028 (forecast) $146.1 Mn +$12.2 Mn +29.9%
2029 (forecast) $159.4 Mn +$13.3 Mn +41.7%
2030 (forecast) $173.9 Mn +$14.5 Mn +54.6%
2031 (forecast) $189.7 Mn +$15.8 Mn +68.6%
2032 (forecast) $206.9 Mn +$17.3 Mn +84%
2033 (forecast) $225.8 Mn +$18.8 Mn +100.7%
2034 (forecast) $246.3 Mn +$20.5 Mn +119%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $4.08 Bn
  2. North America $1.90 Bn
  3. US $1.85 Bn
  4. Europe $746.2 Mn
  5. APAC $767.3 Mn
  6. China $339.4 Mn
  7. Canada $321.5 Mn
  8. Japan $246.1 Mn
  9. Latin America $208.6 Mn
  10. Middle East $152.3 Mn
  11. Germany $130.8 Mn
  12. Brazil (this report) $112.5 Mn
  13. UK $98.3 Mn
  14. France $94.2 Mn
  15. Italy $93.5 Mn
  16. Ecuador $89.6 Mn
  17. Spain $72.2 Mn
  18. Saudi Arabia $72.4 Mn
  19. India $69.0 Mn
  20. Mexico $62.1 Mn
  21. Africa $59.1 Mn
  22. Australia $54.3 Mn
  23. Russia $42.2 Mn
  24. New Zealand $38.6 Mn
  25. South Africa $29.7 Mn
  26. UAE $21.8 Mn
  27. Egypt $12.9 Mn
  28. Philippines $7.8 Mn
  29. Malaysia $6.8 Mn
  30. Hong Kong $6.5 Mn
  31. Thailand $5.5 Mn
  32. Singapore $5.1 Mn
  33. Kenya $3.0 Mn

The Brazil Narcolepsy Treatment Market Analysis Executive Summary

Narcolepsy treatments reduce daytime sleepiness and sudden muscle weakness in people with this sleep disorder.

Key segments of the narcolepsy Treatment market include drug class (Oxybates, Wake-Promoting Agents and H3 Antagonists) and type (Type 1 and Type 2).

Brazil Narcolepsy Treatment Market Dynamics

Market Growth Drivers

An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the narcolepsy Treatment market.

Opportunity

Biomarker-guided treatment, earlier diagnosis and new device-based therapies give the narcolepsy Treatment market strong room to grow.

Market Restraints

Hard-to-reach brain targets, high failure rates in trials, side effects and high prices for new therapies hold back the narcolepsy Treatment market.

Competitive Landscape for Narcolepsy Treatment Market in Brazil

The narcolepsy Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Narcolepsy Treatment Market in Brazil

Narcolepsy Treatment in Brazil: rules and payment

Medicines need registration with ANVISA, the National Health Surveillance Agency, before sale.⁠[1] The Unified Health System (SUS) gives free public care to everyone, and CONITEC advises which medicines and technologies it adds.⁠[2]

[1] ANVISA. Checked 14 Nov 2026.

[2] CONITEC. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for narcolepsy Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Brazil.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Narcolepsy Treatment right now, from free public sources.

Latest research 23 papers since 2021 (worldwide)

  1. Guidelines for daily sodium intake: a counterpoint to the current recommendation for low sodium intake. Sleep advances : a journal of the Sleep Research Society, 2026
  2. Production of Chitosan-PVA Coated Vitamin E and Ephedrine Nanoparticles Using Electrospraying for the Treatment of Narcolepsy. Molecules (Basel, Switzerland), 2026
  3. Practical Guidance for Initiation and Management of Patients on Once-Nightly Sodium Oxybate for Narcolepsy Treatment: Modified Delphi Panel Consensus Recommendations. Neurology and therapy, 2026
  4. Dissolution of Once-Nightly Sodium Oxybate in Soft Foods and Alternative Liquid Reconstitution Vehicles. Clinical therapeutics, 2025
  5. Narcolepsy: a machine learning bibliometric analysis (1996-2024). Frontiers in neurology, 2025
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Narcolepsy Treatment in context

Brazil compared

  • Health spending per person: 1,010 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 4 countries we cover in Latin America.[1]
  • Doctors: 2.36 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 2nd highest of the 4 countries we cover in Latin America.[2]
  • People aged 65 and over: 11.5% of people (2025). World: 10.4% of people (2025). Highest of the 4 countries we cover in Latin America.[3]

Questions, answered with public data

How much research is published on Narcolepsy Treatment?
PubMed lists 23 papers added since January 2021 that match this market, worldwide.[4]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.

[4] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Narcolepsy Treatment in Brazil? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Adaptogens: Ancient Herbs, Modern Market170 WHO Member States report the use of traditional medicine. Adaptogens like ashwagandha, rhodiola and… Stress and Mood Supplements: Ashwagandha and BeyondDepression and anxiety cost the world about US$1 trillion a year. Ashwagandha has some evidence for stress… Sleep Aids: Why So Many People Can't SleepAbout 3 in 10 US adults sleep less than 7 hours. Melatonin helps with jet lag and shift work, but its effect…
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in Brazil

See all
Same topic, other categories

Related on brain and nerves and sleep

See the topic